The effect of sCD4 on the binding and accessibility of HIV-1 gp41 MPER epitopes to human monoclonal antibodies

Virology. 2010 Dec 20;408(2):213-23. doi: 10.1016/j.virol.2010.09.029. Epub 2010 Oct 20.

Abstract

Two human monoclonal anti-HIV-1 antibodies, 2F5 and 4E10, were utilized to investigate the accessibility and conservation of gp41 MPER epitopes on five different clades of HIV-1 in the absence and presence of sCD4. The binding of human monoclonal antibodies (mAbs) to HIV-1 was dependent upon the virus clade. Soluble CD4 significantly increased the accessibility of gp41 MPER-binding epitopes on several isolates that previously showed little or no binding with 2F5 and 4E10 mAbs as determined by a modified ELISA-based virus capture assay and surface plasmon resonance. Studies on the relationship between virus binding and neutralization in a TZM-bl pseudovirus assay indicated that in most cases, mAbs that exhibited neutralization also bound the virus. However, neither binding per se nor the total envelope content per virion was a predictor of neutralization. The hidden or conformational gp41 MPER epitopes unmasked by sCD4 may provide additional targets for vaccine design.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Antibodies, Monoclonal / metabolism*
  • Antibodies, Neutralizing / metabolism
  • CD4 Antigens / metabolism*
  • Epitopes / genetics
  • Epitopes / metabolism
  • Genes, Viral
  • HIV Antibodies / metabolism*
  • HIV Envelope Protein gp41 / genetics
  • HIV Envelope Protein gp41 / immunology*
  • HIV-1 / genetics
  • HIV-1 / immunology*
  • HIV-1 / isolation & purification
  • Humans
  • In Vitro Techniques
  • Mutation
  • Peptide Fragments / genetics
  • Peptide Fragments / immunology
  • Solubility
  • Surface Plasmon Resonance

Substances

  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • CD4 Antigens
  • Epitopes
  • HIV Antibodies
  • HIV Envelope Protein gp41
  • Peptide Fragments
  • gp41 protein, Human immunodeficiency virus 1